Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-20T15:36:11.749Z Has data issue: false hasContentIssue false
  • English
  • Français

Low cholesterol and violent death

Published online by Cambridge University Press:  13 June 2014

Francis M Corrigan ,
Ronald F Gray  and
E Roy Skinner
Francis M Corrigan
Affiliation:
Argyll and Bute Hospital, Lochgilphead, Scotland
Ronald F Gray
Affiliation:
Royal Cornhill Hospital, Aberdeen, Scotland
E Roy Skinner
Affiliation:
Department of Molecular and Cell Biology, University of Aberdeen, Scotland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Irish Journal of Psychological Medicine , Volume 10 , Issue 3 , October 1993 , pp. 166
Copyright
Copyright © Cambridge University Press 1993

References

1a.Conroy, R. Low Cholesterol and violent death: the evidence, the gaps, the theory and the practical implications. Ir J Psychol Med 1993;2:67–70.CrossRefGoogle Scholar
1b.Lagrost, L, Gambert, P, Meunier, S, Morgado, P, Desgres, J, d'Athis, P, Lallemant, C. Correlation between apolipoprotein A–IV and triglyceride concentrations in human sera. J Lipid Res 1989; 30: 701–10.CrossRefGoogle ScholarPubMed
2.Gray, RF, Corrigan, FM, Strathdee, A, Skinner, ER, Van Rhijn, AJ, Horrobin, DF. Cholesterol metabolism and violence: a study of individuals convicted of violent crimes. NeuroReport 1993; 4: 754–6.CrossRefGoogle ScholarPubMed
3.Virkkunen, M. Serum cholesterol in antisocial personality. Neuropsychobiology 1979; 5: 27–30.CrossRefGoogle ScholarPubMed
4.McLoughlin, I, Clark, P. Lipid-lowering drugs. Br J Psychiatry 1989; 154: 275–6.CrossRefGoogle ScholarPubMed
5.Horrobin, DF. Lipid-lowering drugs and violence. Br J Psychiatry 1989; 154.Google ScholarPubMed
6.Muldoon, MF, Manuck, SN, Matthews, KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309–14.CrossRefGoogle ScholarPubMed
7.Lagrost, L, Gambert, P, Athias, A, Lallemant, C. Metabolic role of human apoprotein A–IV. Adv Exp Med Biol 1991; 285: 109–15.CrossRefGoogle ScholarPubMed
8.Boyles, JK, Pitas, RE, Wilson, E, Mahley, RW, Taylor, JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985; 76: 1501–13.CrossRefGoogle ScholarPubMed
9.Pitas, RB, Boyles, JK, Lee, SH, Foss, D, Mahley, RW. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta (1987); 917: 148–61.CrossRefGoogle ScholarPubMed
10.Ignatius, MJ, Gebicke-Harter, PJ, Pate Skene, JH, Schilling, JW, Weisgraber, KH, Mahley, RW, Shooter, EM. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA February 1986; 83: 1125–9.CrossRefGoogle ScholarPubMed
11.Poireir, J, Hess, M, May, PC, Finch, CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991; 11: 97–106.CrossRefGoogle Scholar
12.Saunders, AM, Schmader, M, Breitner, JCS, Benson, MD, Brown, WT, Goldfarb, L, et al.Apolipoprotein Eϵ4 allele distributors in late-onset Alzheimer's disease and in other amyloid forming diseases. Lancet 1993; 342: 710–1.CrossRefGoogle Scholar
13.Bockxmeer, RM, Mamotte, CDS. Apolipoprotein ϵ4 homozygosity in young men with coronary heart disease. Lancet 1992; 340: 879–80.CrossRefGoogle ScholarPubMed